SEATTLE, WA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)THE GOUT HYPERURICEMIA AND CRYSTAL-ASSOC IATED DISEASE NETWORK, founded in 2015, is a small nonprofit in the Health Care sector that reported $218K in total revenue in fiscal year 2023. Revenue surged 24% from the prior year, signaling strong growth momentum. Expenses of $321K exceeded revenue, resulting in a 47% operating deficit.
LAUNCH AND SUPPORT NOVEL RESEARCH AND EDUCATION INITIATIVES TO HELP FILL THE KNOWLEDGE GAP IN THE PATHOGENESIS, DIAGNOSIS, TREATMENT, AND OUTCOMES OF GOUT, HYPERURICEMIA, AND CRYSTAL DEPOSITION-ASSOCIATED DISORDERS (INCLUDING CARDIOVASCULAR DISEASES AND RENAL DISEASES ASSOCIATED WITH THESE CONDITIONS); FACILITATE THE SHARING OF RESOURCES AND INFORMATION RELATED TO GOUT, HYPERURICEMIA, AND CRYSTAL-ASSOCIATED DISEASES; AND FOSTER NETWORKING AND COLLABORATION ACROSS RELATED MEDICAL DISCIPLINES AND SCIENTIFIC COMMUNITIES THAT CARE FOR AND STUDY THESE CONDITIONS.THE LARGER AIMS OF G-CAN ARE TO GROW NETWORKING BETWEEN DIFFERENT MEDICAL SPECIALTIES THAT CARE FOR PATIENTS WITH THE AFOREMENTIONED CONDITIONS, AND TO THEREBY ADVANCE RESEARCH, THERAPY, AND PROVIDER AND PATIENT EDUCATION.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $218,468 | $176,862 | +0.2% |
| Expenses | $320,642 | $149,575 | +1.1% |
| Net Income | $-102,174 | $27,287 | -4.7% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| ROBERT TERKELTAUB MD | PRESIDENT | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| HYON K CHOI MD | VICE PRESIDENT/TREASURER | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| NICOLA DALBETH | STEERING COMMITEE MEMBER | 0.25 |
Director
|
$0 | $0 | $0 |
| FREDERIC LIOTE | STEERING COMMITEE MEMBER | 0.25 |
Director
|
$0 | $0 | $0 |
| TONY MERRIMAN | STEERING COMMITEE MEMBER | 0.25 |
Director
|
$0 | $0 | $10,625 |
| DAVID MOUNT | STEERING COMMITEE MEMBER | 0.25 |
Director
|
$0 | $0 | $0 |
| TUHINA NEOGI | STEERING COMMITEE MEMBER | 0.25 |
Director
|
$0 | $0 | $0 |
| ALEX SO | STEERING COMMITEE MEMBER | 0.25 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $218,468 | $320,642 | $623,517 | $-102,174 |
| 2022 | $176,862 | $149,575 | $725,838 | $27,287 |
| 2021 | $176,244 | $60,999 | $697,300 | $115,245 |
| 2020 | $144,159 | $63,731 | $585,136 | $80,428 |
| 2019 | $251,059 | $114,642 | $501,605 | $136,417 |
| 2018 | $108,133 | $94,345 | $365,188 | $13,788 |
Compare THE GOUT HYPERURICEMIA AND CRYSTAL-ASSOC IATED DISEASE NETWORK with other nonprofits in Washington and across the country.